Skip to content

Carl Dambkowski, Director at Oruka Therapeutics, sold ORKA on Jun 12, 2026

Data as of Oct 16

▼ SELL$882K12,583 shares at $70.11Carl Dambkowski DirectorORKA Oruka Therapeutics, Inc.
Watch ORKA
Traded
Jun 12, 2026
Disclosed
Jun 12, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Carl Dambkowski, Director at Oruka Therapeutics, sold ORKA on Jun 12, 2026TRADEDDISCLOSED
ORKASimilar stocks (XLV — its sector index fund), rebased to ORKA's price on the disclosure day
ORKA since disclosure
+2.9%
after the sale
Similar stocks (XLV) since disclosure
+14.9%
XLV — its sector index fund

Change in closing price from Jun 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLCarl Dambkowski DirectorORKA Oruka Therapeutics, Inc.$1.6Mdisclosed Jun 12 · filed 1 day after the trade

See every trade on ORKA →